1. The Korean Neurosurgical Society. Neurosurgery. 3rd ed. Seoul: Joongang. 2005:242–3, 582.
2. Min SG. Modern Psychiatry. 5th ed. Seoul: Ilchokak. 2010:203.
3. Lee BY. ICD-10. Seoul: Ilchokak. 1994:63–6.
4. Han SH, Kil GJ. Effects of a Mixture Ginseng Radix, Chaenomelis Fructus on the Mice Model of Alzheimer’s Disease. Kor J Herbology. 2007;22(1):41–8.
5. Alstiel LD, Sperber K. Cytokines in Alzheimer’s disease. Prog Neuropsychopharmacol Biol Psychiatry. 1991;15(4):481–95.
6. Jeongughanuigwadaehag Singyeongjeongsingwa Gyogwaseopyeonchanwiwonhoe. Hanuisingyeo ngjeongsingwahag. Seoul: Jipmoondang. 2011:332335–6, 339.
7. Chon JS, Chun SI, Park SH, Baek SY, Kim DA. Recent Epidemiologic Trends of Stroke. Ann Rehabil Med. 1998;22(6):1159–65.
8. Myung HJ, Lee SB, Rho JK, et al. Current Status of Cerebrovascular Disease in Korea. J Korean Neurol Assoc. 1989;7(2):179–87.
9. Kim KN, Choi MJ, Lee YH, Cho SH. The Protective and Recovery Effects of Peucedanum Japonicum Thunberg for Vascular Dementia. J of Oriental Neuropsychiatry. 2013;24(1):123–9.
10. Xue J. Boyeongchwalyo. Shanghai: Sanghaegojeog. 1991:95.
11. Hwang EW. Donguijeongsinuihag. Seoul: Hyeondaeuihagseojeogsa. 1987:608615–6, 632688892.
12. Jung JH. Neuroprotective effects of Uk-Gan San on the Parkinson’s disease model [dissertation]. Seoul: Kyung Hee Univ, 2011. Korean.
13. Cho MY, Shin YJ, Ha YJ, et al. Protective Effects of Ukgan-san in CoCl2-induced Cell Death of C6 Glial Cells. Korean J Orient Int Med. 2013;34(2):178–91.
14. Doo AR, Kim SN, Park JY, et al. Neuroprotective effects of an herbal medicine, Yi-Gan San on MPP+/MPTP-induced cytotoxicity in vitro and in vivo. J Ethnopharmacol. 2010;131(2):433–42.
15. Iizuka S, Kawakami Z, Imamura S, et al. Electron-microscopic examination of effects of yokukansan, a traditional Japanese medicine, on degeneration of cerebral cells in thiamine-deficient rats. Neuropathology. 2010;30(5):524–36.
16. Nogami A, Takasaki K, Kubota K, et al. Effect of yokukansan on memory disturbance in an animal model of cerebrovascular dementia. Journal of Traditional Medicines. 2013;30(4):164–75.
17. Liu Y, Nakamura T, Toyohia T, Lu F, Yamamoto T, Itano T. Ameliorative effects of Yokukansan on behavioral deficits following ischemic dementia in gerbils. Brain Res. 2014;1543:300–7.
18. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20(1):84–91.
19. Jeongughanuigwadaehag Hanuihagjeonmunda ehagwon Gyeonglaggyeonghyeolhag Gyojaepy eonchanwiwonhoe. Details of Meridians & Acu-points (Volume II). Gangwon: Uibang. 2008:981.
20. Lindsay Kenneth W. Clinical Neurology. Seoul: Korea: 1997:199–210, 414424.
21. Diez M, Koistinaho J, Kahn K, Games D, Hok-felt T. Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F beta-amyloid precursor protein-initial observations. Neuroscience. 2000;100(2):259–86.
22. Han YS. A Study on the Welfare Service Improvement of the Old with Dementia [dissertation]. Seoul: Hanyang Univ, 2011. Korean.
23. Choi SH, Ku SK, Cheon WH, et al. Diagnosis, Treatment and Prevention of Subcortical Vascular Dementia with a Case Report. Kor J Oriental Preventive Medical Society. 2010;14(3):63–75.
24. Kwak DI. Senile Dementia. J Korean Geriatr Psychiatry. 1997;1(1):3–15.
25. Lee YJ, Han CH, Jeon WK, Baek KM, Cheon WH, Choi SH. A review study of treatment effects for vascular dementia. Kor J Oriental Preventive Medical Society. 2011;15(2):51–67.
26. Chen H. Silyongjunguinoebyeonghag. Beijing: Hagwon. 1993:242–51, 784–91.
27. Sisudomyeong. Hanbanghuseyobanghaeseol. Seoul: Dongyangjonghabtongsingyoyugchulpanbu. 1974:61.
28. Kim IS. The Effects of Dexamethasone and MK-801 on Edema Formation in Middle Cerebral Artery Occlusion Model of the Rat. Korean J Anesthesiol. 1999;37(2):327–33.
29. Pulsinelli WA, Brierley JB, Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol. 1987;11:491–8.
30. Jeong BG, Yoon BS, Park SG. EFFECTS of MEDIAL SEPTAL LESIONS on MORRIS WATER MAZE LEARNING in RATS. The Korean Journal of Cognitive and Biological Psychology. 1993;5:29–44.
31. Kum JH, Shin KY, Suh YH. Differences in rat’s behavioral propensity about learning and memory or drug effect. In: Proceedings of the Korean Society for Cognitive Science Conference; 2005 May 28; Seoul, Korea, Seoul. Antscommunication. 2005;
32. Diamond DM, Fleshner M, Ingersoll N, Rose GM. Psychological stress impairs spatial working memory: relevance to electrophysiological studies of hippocampal function. Behav Neurosci. 1996;110(4):661–72.
33. Choi JH. Bax Protein in Cancer Treatment. J Korean Med Assoc. 2007;50(11):1016–22.
34. Kim HK, Kim PJ, Baik SW, Kim IS, Chung KS. Molecular Biologic Study on tbe Changes of Glutamate Receptor (mGluR5) in Rat Hippocampus after Brain Ischemia. Korean J Crit Care Med. 2000;15(2):75–81.
35. Amet LE, Lauri SE, Hienola A, et al. Enhanced hippocampal long-term potentiation in mice lacking heparin-binding growth-associated molecule. Mol Cell Neurosci. 2001;17(6):1014–24.
36. Noh MH, Yong JH, Kim GY, Kim DH. Neuroanatomy & Neurophysiology. Seoul: Cheonggu. 2005:106–7.
37. Nagy ZS, Esiri MM. Apoptosis-related protein expression in the hippocampus in Alzheimer’s disease. Neurobiol Aging. 1997;18:545–71.
38. Kasa P, Rakonczay Z, Gulya K. The Cholinergic system in Alzheimer’s disease. Prog Neurobiol. 1997;52(6):511–35.
39. Kim KH. The Review of Clinical Studies on Acupuncture Treatment of Vascular Dementia [dissertation]. Iksan: Wonkwang Univ, 2014. Korean.